2026-04-26T23:30:33Zhttps://repisalud.isciii.es/rest/oai/request
oai:repisalud.isciii.es:20.500.12105/179882024-11-28T15:14:13Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927col_20.500.12105_16961
Repisalud author Hox, Valerie author Lourijsen, Evelijn author Jordens, Arnout author Aasbjerg, Kristian author Agache, Ioana author Alobid, Isam author Bachert, Claus author Boussery, Koen author Campo, Paloma author Fokkens, Wytske author Hellings, Peter author Hopkins, Claire author Klimek, Ludger author Mäkelä, Mika author Mösges, Ralph author Mullol, Joaquim author Pujols, Laura author Rondon, Carmen author Rudenko, Michael author Toppila-Salmi, Sanna author Scadding, Glenis author Scheire, Sophie author Tomazic, Peter-Valentin author Van Zele, Thibaut author Wagemann, Martin author van Boven, Job F. M. author Gevaert, Philippe authoraffiliation [Hox,V] Cliniques Universitaires Saint-Luc Brussels, Brussels, Belgium. [Lourijsen,E; Fokkens,W] Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands. [Jordens,A; Bachert,C; Van Zele,T; Gevaert,P] Upper Airway Research Laboratory, Dep. of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium. [Aasbjerg,K] Bispebjerg University Hospital, Copenhagen, Denmark. [Agache,I] Faculty of Medicine, Transsylvania University, Brasov, Romania. [Alobid,I; Mullol,J; Pujols,L] Hospital Clínic, IDIBAPS, CEBERES Universitat de Barcelona, Catalonia, Spain. [Alobid,I] Centro Medico Teknon, Barcelona, Spain. [Bachert,C] Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden. [Boussery,K; Scheire,S] Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. [Campo,P; Rondon,C] Allergy Unit, Hospital Regional Universitario of Málaga, IBIMA, ARADyAL, Malaga, Spain. [Hellings,P] Department of Ear, Nose and Throat Disease, University Hospitals, Louvain, Belgium. [Hopkins,C] ENT Department, Guy’s & St Thomas’ Hospital, London, UK. [Klimek,L] Center of Rhinology and Allergology, Wiesbaden, Germany. [Mäkelä,M; Toppila‑Salmi,S] Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. [Mösges,R] University of Cologne, Cologne, Germany. [Rudenko,M] London Allergy and Immunology Center, London, UK. [Scadding,G] Royal National Throat, Nose and Ear Hospital, London, UK. [Tomazic,PV] Medical University Graz, Graz, Austria. [Wagemann,M] Heinrich-Heine-University, Düsseldorf, Germany. [van Boven,JFM] Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands. 2024-02-12T19:45:08Z 2024-02-12T19:45:08Z 2020-01-03 http://hdl.handle.net/10668/3699 http://hdl.handle.net/20.500.12105/17988 31908763 10.1186/s13601-019-0303-6 2045-7022 Clinical and Translational Allergy Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease. eng Glucocorticosteroids Rhinitis Rhinosinusitis Glucocorticoides Rinitis Sinusitis Pólipos nasales Corticoesteroides Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper review article